Renflexis 100 MG vials
Ended Awarded Last action
- Contract number
- SPE2DR26FQS7F
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $57,932
Award facts
- Contract value 100% obligated
- $57,931.76 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $57,931.76 delivery order to AmerisourceBergen Drug Corp for the supply of Renflexis 100 mg vials. This contract, which became effective on December 22, 2025, with an ultimate completion date of December 23, 2025, represents a firm fixed-price delivery order with no set-aside designation. The award was issued competitively under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania.
This delivery order supports the DLA's mission to provide critical pharmaceutical supplies to military and veteran healthcare systems. Renflexis is a biosimilar to Remicade used in treating inflammatory conditions, and its procurement through the established prime vendor contract demonstrates the continued importance of reliable pharmaceutical supply chains for federal medical operations. The award reflects AmerisourceBergen's role as a major pharmaceutical distributor capable of meeting federal procurement requirements through the comprehensive global pharmaceutical support vehicle that enables supply of brand-name and generic drugs, specialty medications, vaccines, and related medical commodities across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26FQS7F?
SPE2DR26FQS7F was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 22, 2025.
How much is contract SPE2DR26FQS7F worth?
The government has obligated $57,932 on SPE2DR26FQS7F.
Is contract SPE2DR26FQS7F an order under another contract?
Yes. SPE2DR26FQS7F is a delivery order under SPE2DR25D1022, an indefinite delivery contract.
Was contract SPE2DR26FQS7F competed?
The extent of competition for SPE2DR26FQS7F was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award